
June 2 (Reuters) - Nxera Pharma Co Ltd 4565.T:
NXERA PHARMA CO LTD: NXERA PHARMA ACHIEVES DEVELOPMENT MILESTONE IN COLLABORATION WITH ELI LILLY TARGETING METABOLIC DISEASES
NXERA PHARMA CO LTD: UNDER TERMS OF AGREEMENT, NXERA IS ELIGIBLE TO RECEIVE DEVELOPMENT AND COMMERCIAL MILESTONES TOTALLING UP TO US$694 MILLION, PLUS TIERED ROYALTIES ON GLOBAL SALES